Non-binding site modulation of G protein-coupled receptor signalling

By Jones P.G.   Macdonald S.G.   Cockett M.I.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. : 1641-1654

Informa Healthcare

Access to resources Recommend Favorite

P2Y receptor specific for diadenosine tetraphosphate in lung: selective inhibition by suramin, PPADS, Ip 5 I, and not by MRS-2197

By Laubinger W.   Wang H.   Welte T.   Reiser G.  

European Journal of Pharmacology, Vol. 468, Iss. 1, 2003-05 ,pp. : 9-14

Elsevier

Access to resources Recommend Favorite

Editorial [Hot Topic: G Protein-Coupled Receptor Drug Targets (Executive Editors: P.M. Sexton and A. Christopoulos)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 14, 2006-05 ,pp. : 1681-1682

Bentham Science Publishers

Access to resources Recommend Favorite

Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity

By Harden T.K.   Lazarowski E.R.   Boucher R.C.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 2, 1997-02 ,pp. : 43-46

Elsevier

Access to resources Recommend Favorite

Increased expression of G protein-coupled receptor kinases in cystic fibrosis lung

By Mak J.C.W.   Chuang T.-T.   Harris C.A.   Barnes P.J.  

European Journal of Pharmacology, Vol. 436, Iss. 3, 2002-02 ,pp. : 165-172

Elsevier

Access to resources Recommend Favorite